These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6576783)

  • 1. Migration of K562 cells and its inhibition by lymphokines.
    Hering S
    Biomed Biochim Acta; 1983; 42(1):123-7. PubMed ID: 6576783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of migration of tumor cells in vitro by lymphokine-containing supernatants.
    Cohen MC; Goss A; Yoshida T; Cohen S
    J Immunol; 1978 Sep; 121(3):840-3. PubMed ID: 99477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokine-mediated stimulation of eosinophil migration in the guinea-pig.
    van den Berg WB; van Tuyl J; Sminia P; Jentjens TM; Scheper RJ
    Immunology; 1981 Nov; 44(3):481-8. PubMed ID: 7319548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the lymphokine responsible for migration-inhibitory activity against tumor cells.
    Cohen MC
    Cancer Res; 1982 Jun; 42(6):2135-8. PubMed ID: 6978764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil migration inhibition factor from T lymphocytes (NIF-T): selective removal of biologic activity by human peripheral blood neutrophils, myelocytic leukemia cells, and differentiated HL-60 cells.
    Weisbart RH; Lusis AJ; Chan G; Billing R; Ashman RF; Golde DW
    J Immunol; 1982 Jan; 128(1):457-62. PubMed ID: 6976379
    [No Abstract]   [Full Text] [Related]  

  • 6. A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro.
    Geczy CL; Hopper KE
    J Immunol; 1981 Mar; 126(3):1059-65. PubMed ID: 7462626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphokine-induced migration inhibition of murine tumor cells derived from solid neoplasms.
    Donskoy M; Forouhar F; Cohen MC
    Cancer Res; 1984 Sep; 44(9):3870-2. PubMed ID: 6430556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines.
    Ralph P; Nakoinz I
    Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discrimination of nonspecific effects in the macrophage-electrophoretic-mobility test using dimethyl sulfoxide].
    Wagner H; Irmscher J; Kotzsch M; Grossmann H; Müller M
    Biomed Biochim Acta; 1983; 42(1):129-37. PubMed ID: 6192810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migration inhibition of endothelial cells by lymphokine-containing supernatants.
    Cohen MC; Picciano PT; Douglas WJ; Yoshida T; Kreutzer DL; Cohen S
    Science; 1982 Jan; 215(4530):301-3. PubMed ID: 6797069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro generation of human activated lymphocyte killer cells: separate precursors and modes of generation of NK-like cells and "anomalous" killer cells.
    Burns GF; Triglia T; Werkmeister JA
    J Immunol; 1984 Sep; 133(3):1656-63. PubMed ID: 6611374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
    Duncan MR; George FW; Hadden JW
    J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophages in resistance to rickettsial infections: characterization of lymphokines that induce rickettsiacidal activity in macrophages.
    Nacy CA; Leonard EJ; Meltzer MS
    J Immunol; 1981 Jan; 126(1):204-7. PubMed ID: 7005333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 is not sufficient for the continuous growth of cloned NK-like cytotoxic cell lines.
    Olabuenaga SE; Brooks CG; Gillis S; Henney CS
    J Immunol; 1983 Nov; 131(5):2386-91. PubMed ID: 6605387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of lymphokine and lipopolysaccharide to induce procoagulant activity in mouse macrophage cell lines.
    Farram E; Geczy CL; Moon DK; Hopper K
    J Immunol; 1983 Jun; 130(6):2750-6. PubMed ID: 6602180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the early and late stages of myelomonocytic leukemia induced by Friend helper-independent virus F-MuLV: isolation and induction of Friend myelomonocytic leukemic cell lines.
    Shibuya T; Mak TW
    J Cell Physiol; 1983 Dec; 117(3):283-9. PubMed ID: 6581171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells.
    Wang Q; Li N; Wang X; Shen J; Hong X; Yu H; Zhang Y; Wan T; Zhang L; Wang J; Cao X
    Life Sci; 2007 Jan; 80(5):420-9. PubMed ID: 17097684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appearance of asialo GM1 glycosphingolipid on the cell surface during lymphokine-induced differentiation of M1 cells.
    Akagawa KS; Momoi T; Nagai Y; Tokunaga T
    FEBS Lett; 1981 Jul; 130(1):80-4. PubMed ID: 6945185
    [No Abstract]   [Full Text] [Related]  

  • 20. Intracellular replication and lymphokine-induced destruction of Leishmania tropica in C3H/HeN mouse macrophages.
    Nacy CA; Meltzer MS; Leonard EJ; Wyler DJ
    J Immunol; 1981 Dec; 127(6):2381-6. PubMed ID: 7299130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.